Numinus Wellness Inc. (NUMIF)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CAD m | 1 | 2 | 6 | 23 | 4 | - | 7 | - |
| Operating profit | CAD m | -12 | - | ||||||
| Net profit | CAD m | -10 | -19 | -45 | -30 | -20 | - | 7 | 3 |
| EPS reported | CAD | -0.05 | 0.02 | ||||||
| Operating cashflow per share | CAD | -0.06 | -0.01 | ||||||
| Capex per share | CAD | 0.00 | 0.00 | ||||||
| FCF per share | CAD | -0.06 | -0.01 | ||||||
| Free cash flow | CAD m | -18 | 1 | ||||||
| Net debt | CAD m | -2 | 1 | ||||||
| Book value equity | CAD m | 1 | - | ||||||
| Book value per share | CAD | 0.00 | -0.01 | ||||||
| Number of shares | m | 295.14 | 295.14 | ||||||
| DPS (TTM paid) | CAD | 0.00 | 0.00 |
Financial summary
Financials in CAD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 13.01 | -9.44 | ||||||
| P/S LTM | x | 2.26 | 2.65 | ||||||
| P/FCF LTM | x | -0.54 | 14.88 | ||||||
| EV/EBITDA LTM | x | -0.68 | -26.46 | ||||||
| EV/Sales LTM | x | 2.28 | 5.29 | ||||||
| Earnings Yield LTM | % | -2.08% | -67.28% | ||||||
| FCF Yield | % | -185.50% | +6.72% | ||||||
| Quality | |||||||||
| ROE | % | -2707.8% | +833.04% | ||||||
| ROIC | % | -4.24% | -3.24% | ||||||
| Operating margin | % | -2.81% | -75.23% | ||||||
| Gross margin | % | +27.97% | +41.47% | ||||||
| FCF/Sales | % | -419.89% | -97.38% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -82.02% | +64.88% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -8.61 | 0.77 | ||||||
| Net Debt/EBITDA | x | -0.01 | -0.15 | ||||||
| EBIT/Net interest | x | -118.53 | -33.26 | ||||||
| Net debt/market cap | % | +2.18% | +1.43% | ||||||
| Net debt/Equity | x | -2.42 | - | ||||||
| Gross debt/equity | x | 2.80 | - | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Numinus Wellness Inc. is dedicated to pioneering and delivering psychedelic-assisted psychotherapy, with the overarching goal of reshaping the mental healthcare landscape. The company's operations are segmented into two primary divisions: Salvation Botanicals and Numinus Health. Salvation Botanicals provides comprehensive laboratory services focused on psychedelics, encompassing cultivation, analytical testing, product research and development, and various ancillary supports. Additionally, this division offers both full-suite and bespoke testing for cannabis products. Numinus Health concentrates on promoting healing, connection, and personal growth through a range of supportive therapies and advanced technologies. This division specializes in addressing mental health challenges and substance abuse, delivering services including psychotherapy, counselling, neurofeedback, physiotherapy, and other therapeutic modalities. Furthermore, Numinus Health equips practitioners with vital training, facilities, and operational resources. The company's headquarters are situated in Vancouver, Canada.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Numinus Wellness Inc. is dedicated to pioneering and delivering psychedelic-assisted psychotherapy, with the overarching goal of reshaping the mental healthcare landscape. The company's operations are segmented into two primary divisions: Salvation Botanicals and Numinus Health. Salvation Botanicals provides comprehensive laboratory services focused on psychedelics, encompassing cultivation, analytical testing, product research and development, and various ancillary supports. Additionally, this division offers both full-suite and bespoke testing for cannabis products. Numinus Health concentrates on promoting healing, connection, and personal growth through a range of supportive therapies and advanced technologies. This division specializes in addressing mental health challenges and substance abuse, delivering services including psychotherapy, counselling, neurofeedback, physiotherapy, and other therapeutic modalities. Furthermore, Numinus Health equips practitioners with vital training, facilities, and operational resources. The company's headquarters are situated in Vancouver, Canada.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free